These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17137468)

  • 21. Treatment of periodontal disease for glycaemic control in people with diabetes.
    Simpson TC; Needleman I; Wild SH; Moles DR; Mills EJ
    Cochrane Database Syst Rev; 2010 May; (5):CD004714. PubMed ID: 20464734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes.
    Egede LE; Mueller M; Echols CL; Gebregziabher M
    Med Care; 2010 Jun; 48(6):527-33. PubMed ID: 20473215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects.
    Promsudthi A; Pimapansri S; Deerochanawong C; Kanchanavasita W
    Oral Dis; 2005 Sep; 11(5):293-8. PubMed ID: 16120115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of periodontal therapy on glycemic control and inflammatory markers.
    O'Connell PA; Taba M; Nomizo A; Foss Freitas MC; Suaid FA; Uyemura SA; Trevisan GL; Novaes AB; Souza SL; Palioto DB; Grisi MF
    J Periodontol; 2008 May; 79(5):774-83. PubMed ID: 18454655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus.
    Llambés F; Silvestre FJ; Hernández-Mijares A; Guiha R; Caffesse R
    Clin Oral Investig; 2008 Dec; 12(4):337-43. PubMed ID: 18446389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of non-surgical periodontal therapy on glycemic control of type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis.
    Cao R; Li Q; Wu Q; Yao M; Chen Y; Zhou H
    BMC Oral Health; 2019 Aug; 19(1):176. PubMed ID: 31387569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus.
    Stewart JE; Wager KA; Friedlander AH; Zadeh HH
    J Clin Periodontol; 2001 Apr; 28(4):306-10. PubMed ID: 11314885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in diabetes medications in the Diabetes and Periodontal Therapy Trial and their effect on hemoglobin A1c (HbA1c).
    Gelato MC; Schoenfeld E; Hou W; Michalowicz B; Seaquist E; Oates T; Tripathy D; Engebretson S; Hyman L
    Contemp Clin Trials; 2016 Sep; 50():21-7. PubMed ID: 27417981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial.
    D'Aiuto F; Gkranias N; Bhowruth D; Khan T; Orlandi M; Suvan J; Masi S; Tsakos G; Hurel S; Hingorani AD; Donos N; Deanfield JE;
    Lancet Diabetes Endocrinol; 2018 Dec; 6(12):954-965. PubMed ID: 30472992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of adjunctive photodynamic therapy on the clinical periodontal, HbA1c and advanced glycation end product levels among mild to moderate chronic periodontal disease patients with type 2 diabetes mellitus: A randomized controlled clinical trial.
    Mirza S; Khan AA; Al-Kheraif AA; Khan SZ; Shafqat SS
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():177-182. PubMed ID: 31394300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment.
    Guo XH; Ji LN; Lu JM; Liu J; Lou QQ; Liu J; Shen L; Zhang MX; Lv XF; Gu MJ
    J Diabetes; 2014 Jul; 6(4):290-7. PubMed ID: 24279284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
    Billings LK; Parkin CG; Price D
    Diabetes Technol Ther; 2018 Aug; 20(8):561-565. PubMed ID: 30044123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study.
    Chen L; Luo G; Xuan D; Wei B; Liu F; Li J; Zhang J
    J Periodontol; 2012 Apr; 83(4):435-43. PubMed ID: 21859323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus.
    Michalowicz BS; Hyman L; Hou W; Oates TW; Reddy M; Paquette DW; Katancik JA; Engebretson SP;
    J Am Dent Assoc; 2014 Dec; 145(12):1227-39. PubMed ID: 25429036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.